The Thriving Biopharma Business, 9781032976211
Paperback
Navigate biopharma complexities, drive value, and thrive: your indispensable guide.
Pre-Order

The Thriving Biopharma Business

how to unlock value and drive success in biotech and pharma

$159.53

  • Paperback

    416 pages

  • Release Date

    14 October 2025

Check Delivery Options

Summary

The Thriving Biopharma Business: A Strategic Guide to Success

In today’s fiercely innovative and complex biopharmaceutical industry, successfully managing a pharmaceutical or biotech company from concept to patients requires exceptional strategic, leadership, and managerial abilities. This book is a definitive reference that uniquely integrates critical business, strategy, finance, M&A, regulatory, and intellectual property concepts.

Bringing new therapies to market is b…

Book Details

ISBN-13:9781032976211
ISBN-10:1032976217
Author:Alain Eudaric, Jean-Noël Pellegrin
Publisher:Taylor & Francis Ltd
Imprint:Routledge
Format:Paperback
Number of Pages:416
Release Date:14 October 2025
Weight:453g
Dimensions:229mm x 152mm
What They're Saying

Critics Review

“A practical, straight-to-the-point guide for biotech leaders. It covers everything from valuation to partnerships—knowledge you don’t learn in a lab.”

Adrien Châtillon, CEO and Serial Entrepreneur in Neuroscience

“Congratulations on this book — a rare and insightful work that demystifies business development / mergers & acquisitions in biopharma.”

Loïc Gonnet, Global Head of Mergers & Acquisitions at Sanofi

“A well-rounded and insightful book that covers key aspects of the biopharma industry. A great resource for both experienced professionals and those just starting out.”

Naji Gehchan, MD, MBA, Chief Medical & Development Officer I, Former Head of Global Development at Eli Lilly

About The Author

Alain Eudaric

Alain Eudaric brings over 30 years of global expertise in biopharma, life sciences, and consulting, specializing in strategy, M&A, alliances, and innovation-led growth. He has held leadership roles at Kearney, Thermo Fisher Scientific, and Parexel International, driving transformative programs and business success. As President of Idea Pathways, Alain focuses on driving operational excellence and fostering innovative growth strategies for the biopharma industry. He is an alum from Harvard Medical School, Johns Hopkins University, MIT, Purdue University, and Ecole Centrale de Lille with advanced degrees in Biotech, Business, Science, and Engineering.

Jean-Noël Pellegrin has over 15 years of expertise in M&A and business development, with a proven track record of contributing to several hundred successful transactions. He began his career at EY before most recently joining Sanofi, where he has spent the last 20 years in France and the United States. His 30 years of combined experience across global public company financa, audit, accounting, and strategic transactions make him a trusted expert in valuing life sciences assets and structuring complex deals. He is an alum of Babson College and Sciences Po, with advanced degrees in Business and Finance.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.